Linked Life Data

20452542

Source:http://linkedlifedata.com/resource/pubmed/id/20452542

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-5-10
pubmed:abstractText
Thoracic aortic aneurysm is a major health problem with multiple causes and potentially devastating consequences. At present, no large randomized trial has shown that medical therapy can significantly slow or halt the progressive dilatation that eventually leads to dissection and rupture. Surgical therapy, on the other hand, is very effective at preventing these feared complications. A recent study suggested that angiotensin-receptor blocking agents slow the development of aneurysm dilatation in Marfan syndrome. The authors argue that because of the multiple possible causes of aneurysm formation and the potential downsides of therapy, the available evidence is not strong enough to suggest that all patients with thoracic aortic aneurysm should be treated with angiotensin-receptor blocking agents.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1558-2264
pubmed:author
pubmed:copyrightInfo
Copyright 2010 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
279-85
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Is losartan the true panacea for aneurysm disease? CON.
pubmed:affiliation
Department of Medicine, Virginia Commonwealth University, PO Box 980051, Richmond, VA 23298, USA.
pubmed:publicationType
Journal Article, Comment, Review